STOCK TITAN
  1. Home
  2. Sec-filings
  3. ARMK
  4. [Form 4] Aramark Insider Trading Activity

Aramark (ARMK) COO exercises 210,402 options and sells 70,634 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Aramark COO, U.S. Food & Facilities Marc A. Bruno reported a series of option exercises and related share dispositions on August 13, 2026. He exercised 210,402 stock options into an equal number of Aramark common shares at exercise prices of $24.58, $29.38, and $26.50 per share on fully vested options that were scheduled to expire between November 2026 and November 2028.

To cover the option exercise price and tax withholding obligations, 139,768 shares of common stock were withheld by Aramark. In addition, Bruno sold 55,245 shares at a weighted average price of $60.92 per share (in trades ranging from $60.35 to $61.34) and 15,389 shares at a weighted average price of $61.42 per share (ranging from $61.35 to $61.50). Overall, the transactions combine option exercises, shares withheld for costs, and open-market sales.

Positive

  • None.

Negative

  • None.
Insider Bruno Marc A
Role COO, U.S. Food & Facilities
Sold 70,634 shs ($4.31M)
Approx. gross sale proceeds $4.31M
Approx. exercise cost $5.59M
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F4 78,689 $0.00 $0.00
Exercise Stock Option (Right to Buy) F5 57,060 $0.00 $0.00
Exercise Stock Option (Right to Buy) F6 74,653 $0.00 $0.00
Exercise Common Stock 78,689 $24.58 $1.93M
Exercise Common Stock 57,060 $29.38 $1.68M
Exercise Common Stock 74,653 $26.50 $1.98M
Exercise Price or Tax Liability Common Stock F1 139,768 $60.35 $8.43M
Sale Common Stock F2 55,245 $60.92 $3.37M
Sale Common Stock F3 15,389 $61.42 $945K
Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 371,306.226 shares (Direct)
Footnotes (6)
  1. F1. Shares withheld by Aramark (the "Issuer") to cover exercise price of options and tax withholding obligations.
  2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.35 to $61.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.35 to $61.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. These options are fully vested and were scheduled to expire on November 18, 2026.
  5. F5. These options are fully vested and were scheduled to expire on November 16, 2027.
  6. F6. These options are fully vested and were scheduled to expire on November 15, 2028.
Options exercised 210,402 shares Stock options converted into Aramark common stock on August 13, 2026
Exercise prices $24.58, $29.38, $26.50 per share Strike prices for three exercised option grants
Shares withheld for costs 139,768 shares Withheld to cover option exercise price and tax withholding obligations
Shares sold at $60.92 55,245 shares Weighted average sale price; trades ranged from $60.35 to $61.34
Shares sold at $61.42 15,389 shares Weighted average sale price; trades ranged from $61.35 to $61.50
Net buy/sell shares 70,634 shares Net sell direction across reported buy/sell transactions
Option expirations Nov 18 2026; Nov 16 2027; Nov 15 2028 Scheduled expirations of fully vested options before exercise
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax withholding obligations financial
"to cover exercise price of options and tax withholding obligations."
Payment of exercise price or tax liability by delivering or withholding securities financial
"transaction_code_description: Payment of exercise price or tax liability"

FAQ

What did Aramark (ARMK) executive Marc A. Bruno report in this Form 4?
Marc A. Bruno reported exercising 210,402 stock options into common shares and a combination of share withholdings for exercise price and taxes plus open-market sales of 70,634 shares on August 13, 2026.

How many Aramark (ARMK) stock options did Marc A. Bruno exercise?
He exercised a total of 210,402 stock options, including 78,689 at $24.58, 57,060 at $29.38, and 74,653 at $26.50 per share, all converting into Aramark common stock on August 13, 2026.

How many Aramark (ARMK) shares were withheld for option costs and taxes?
Aramark withheld 139,768 shares of common stock from Marc A. Bruno to cover the option exercise price and tax withholding obligations associated with the August 13, 2026 option exercises.

How many Aramark (ARMK) shares did Marc A. Bruno sell and at what prices?
He sold 55,245 shares at a weighted average price of $60.92 and 15,389 shares at a weighted average price of $61.42, with transactions occurring in specified price ranges between $60.35 and $61.50 per share.

Were Marc A. Bruno’s Aramark (ARMK) option exercises fully vested?
Yes. The Form 4 notes the exercised options were fully vested and had been scheduled to expire on November 18, 2026, November 16, 2027, and November 15, 2028, respectively, before the August 13, 2026 exercises.

Does this Aramark (ARMK) Form 4 indicate use of a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as being pursuant to such a plan, and the footnotes do not reference any pre-arranged trading plan for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bruno Marc A
(Last)(First)(Middle)
ARAMARK
2400 MARKET STREET
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
COO, U.S. Food & Facilities
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/13/2026M78,689A$24.58449,995.226D
Common Stock08/13/2026M57,060A$29.38507,055.226D
Common Stock08/13/2026M74,653A$26.5581,708.226D
Common Stock08/13/2026F139,768D$60.35(1)441,940.226D
Common Stock08/13/2026S55,245D$60.92(2)386,695.226D
Common Stock08/13/2026S15,389D$61.42(3)371,306.226D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$24.5808/13/2026M78,689 (4)11/18/2026Common Stock78,689$00D
Stock Option (Right to Buy)$29.3808/13/2026M57,060 (5)11/16/2027Common Stock57,060$00D
Stock Option (Right to Buy)$26.508/13/2026M74,653 (6)11/15/2028Common Stock74,653$00D
Explanation of Responses:
1. Shares withheld by Aramark (the "Issuer") to cover exercise price of options and tax withholding obligations.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.35 to $61.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.35 to $61.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. These options are fully vested and were scheduled to expire on November 18, 2026.
5. These options are fully vested and were scheduled to expire on November 16, 2027.
6. These options are fully vested and were scheduled to expire on November 15, 2028.
Remarks:
/s/ Ryan S. Spengler, as Attorney-in-fact08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR